ThermoGenesis Holdings, Inc.
Q1 2013 Earnings Call Transcript

Published: 13 Nov 2012

[Operator:]

Welcome to the Thermogenesis first quarter fiscal 2013 conference call and webcast. Before we begin the call, we remind you that the statements made during this conference call that are not historical facts and are forward looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in these statements, including but not limited to, certain delays beyond the company’s control with respect to market acceptance of new technologies and products, delays in testing and evaluation of products, initiation and successful completion of clinical evaluations and trials for new claims on existing products, regulatory approvals where required, the outcome of potential litigation, capital resources to fully execute business plans, and other risks detailed from time to time in the company’s filings with the SEC. [Operator instructions.] For your information, this call is being recorded, and a replay of this call will be available for seven days by dialing 877-344-7529, and using conference ID 385107. I would now like to turn the call over to Matthew Plavan, chief executive officer. Please proceed, Mr. Plavan.

[Matthew Plavan:]

Thank you, operator. Welcome everyone, and thank you for joining me today. Although it has been just a short while since our last call, we’ve continued to realize progress with our growth strategy and to execute on our business plan. Our core strategy has three fundamental objectives

[Operator:]

[Operator instructions.] Mr. Plavan, at this time I am showing no questions, and would like to turn the conference back to you for any closing remarks.

[Matthew Plavan:]

Okay, great. Well, thank you everyone for joining me again, and we look forward to reporting our progress to you on future calls. Have a great day.